On April 9, 2021 Systems Oncology, an AI-based pharmatech company, reported that Dr. Spyro Mousses, CEO and Co-Founder of Systems Oncology, will present at the BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery on Friday, April 16th at 11.15 AM EST (Press release, Systems Oncology, APR 9, 2021, View Source [SID1234577803]). Systems Oncology will review its unique strategy for leveraging AI-based multi-target discovery, and unveil its transformative RNAi therapeutic platform for creating innovative RNA drugs that can overcome therapy resistance in oncology indications.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A recording of the panel discussion will be available for approximately four hours following the conclusion of the event and can be accessed under the "News and Events" section of the company’s website at www.systemsoncology.com.